TC
CDMO

TFS Capital’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

TFS Capital’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-10,358
Closed -$85K – 1112
2015
Q4 		$85K Sell
10,358
-5,762
-36% -$46.5K 0.01% 672
2015
Q3 		$115K Buy
16,120
+12,468
+341% +$104K 0.01% 794
2015
Q2 		$33K Buy
+3,652
New +$35.1K ﹤0.01% 868
2014
Q4 		– Sell
-3,763
Closed -$36K – 1172
2014
Q3 		$36K Sell
3,763
-55,633
-94% -$623K ﹤0.01% 1006
2014
Q2 		$782K Buy
+59,396
New +$749K 0.06% 491

Other funds holding CDMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

TFS Capital's CDMO Position: Q1 2016 in Review

TFS Capital sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2016, closing a stake of 10,358 shares — an estimated $85K sold.

TFS Capital first reported a position in CDMO in Q2 2014 and held it in 5 quarters. The position peaked at $782K in Q2 2014. 84 funds tracked by Wall St. Rank hold CDMO as of Q1 2016.

  • TFS Capital reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
  • TFS Capital sold 10,358 Avid Bioservices, Inc. Common Stock shares in Q1 2016, an estimated $85K.
  • TFS Capital first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2014 and held it in 5 quarters.
  • TFS Capital's Avid Bioservices, Inc. Common Stock position peaked at $782K in Q2 2014.
  • 84 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2016.

Based on TFS Capital's 13F filing for Q1 2016, filed 10 May 2016.